AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. CellSource Co.,Ltd.
  3. Financials
  4. Total non-current assets

CellSource Co.,Ltd.【JP:4880】

Market cap
¥7.6B
P/E ratio
-55.4x
CellSource processes blood and fat tissue into therapeutic substances for medical institutions offering regenerative medicine treatments like knee osteoarthritis and infertility care.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal non-current assets (Million JPY)YoY (%)
Oct 31, 20251,536-23.41%
Oct 31, 20242,006+55.44%
Oct 31, 20231,291+147.10%
Oct 31, 2022522+24.50%
Oct 31, 2021420+125.28%
Oct 31, 2020186-0.85%
Oct 31, 2019188+21.00%
Oct 31, 2018155

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)